Low relapse rate in younger patients ≤ 60 years old with newly diagnosed FLT3-mutated acute myeloid leukemia (AML) treated with crenolanib and cytarabine/anthracycline chemotherapy Meeting Abstract
| Authors: | Wang, E. S.; Tallman, M. S.; Stone, R. M.; Walter, R. B.; Karanes, C.; Jain, V.; Collins, R. H. |
| Abstract Title: | Low relapse rate in younger patients ≤ 60 years old with newly diagnosed FLT3-mutated acute myeloid leukemia (AML) treated with crenolanib and cytarabine/anthracycline chemotherapy |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419401213 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.566.566 |
| Notes: | Meeting Abstract: 566 -- Source: Wos |
